Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
The FEBS Journal|July 19, 2022
Infection and immunity: 'There Are Things Out There You (Don't) Need To Know About'Inna S Afonina, Eik Hoffmann
Drug Discovery Today|February 1, 2017
How can nanoparticles contribute to antituberculosis therapy?Joana Costa-Gouveia, José A Aínsa, Priscille Brodin, et al.
Toxins|September 7, 2019
Could Mycolactone Inspire New Potent Analgesics? Perspectives and PitfallsMarie-Line Reynaert, Denis Dupoiron, Edouard Yeramian, et al.
Trends in Microbiology|October 19, 2004
ESAT-6 proteins: protective antigens and virulence factors?Priscille Brodin, Ida Rosenkrands, Peter Andersen, et al.
Future Medicinal Chemistry|March 24, 2011
High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discoveryThierry Christophe, Fanny Ewann, Hee Kyoung Jeon, et al.
Molecular Microbiology|November 2, 2002
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microtiAlexander S Pym, Priscille Brodin, Roland Brosch, et al.
EMBO Reports|November 17, 2017
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeletonOk-Ryul Song, Christophe J Queval, Raffaella Iantomasi, et al.
Plos Pathogens|September 15, 2021
Aconitate decarboxylase 1 participates in the control of pulmonary Brucella infection in miceAurore Demars, Armelle Vitali, Audrey Comein, et al.
Pageof 15